Literature DB >> 2095562

The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.

H W Frijlink1, J Visser, N R Hefting, R Oosting, D K Meijer, C F Lerk.   

Abstract

Hydroxypropyl-beta-cyclodextrin was analyzed by HPLC using postcolumn complexation with phenolphthalein and negative colorimetric detection, with a detection limit of 20 micrograms/ml. The pharmacokinetics of beta-cyclodextrin and of hydroxypropyl-beta-cyclodextrin were studied after intravenous administration to permanently cannulated rats. The pharmacokinetic behavior of both cyclodextrins was similar to that of inulin, showing rapid distribution over extracellular fluids. Elimination occurred through glomerular filtration. When a dose of 200 mg/kg beta-cyclodextrin was administered the elimination rate was decreased, probably as a result of nephrotoxicity of beta-cyclodextrin. Within 24 hr after administration most of the cyclodextrin dose was recovered unchanged in urine. After oral administration, only insignificant amounts of intact beta-cyclodextrin were absorbed from the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095562     DOI: 10.1023/a:1015929720063

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  A new method for the determination of inulin in plasma and urine.

Authors:  A HEYROVSKY
Journal:  Clin Chim Acta       Date:  1956 Sep-Oct       Impact factor: 3.786

2.  Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation.

Authors:  S C Szathmary
Journal:  J Chromatogr       Date:  1989-01-27

3.  Determination of cyclodextrins in biological fluids by high-performance liquid chromatography with negative colorimetric detection using post-column complexation with phenolphthalein.

Authors:  H W Frijlink; J Visser; B F Drenth
Journal:  J Chromatogr       Date:  1987-04-10

4.  Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.

Authors:  K Arimori; K Uekama
Journal:  J Pharmacobiodyn       Date:  1987-08

5.  Pharmacokinetic analyses with RUGFIT: an interactive pharmacokinetic computer program.

Authors:  A H Scaf
Journal:  Biopharm Drug Dispos       Date:  1988 Sep-Oct       Impact factor: 1.627

6.  Effect of beta-cyclodextrin on sleeping time induced by barbituric acid derivatives in mice.

Authors:  O Shirakura; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-08       Impact factor: 1.645

7.  Cyclodextrin nephrosis in the rat.

Authors:  D W Frank; J E Gray; R N Weaver
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

8.  Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.

Authors:  A Gerlóczy; A Fónagy; P Keresztes; L Perlaky; J Szejtli
Journal:  Arzneimittelforschung       Date:  1985

9.  Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake.

Authors:  T O Carpenter; J M Pettifor; R M Russell; J Pitha; S Mobarhan; M S Ossip; S Wainer; C S Anast
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

10.  Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins.

Authors:  M E Brewster; K S Estes; T Loftsson; R Perchalski; H Derendorf; G Mullersman; N Bodor
Journal:  J Pharm Sci       Date:  1988-11       Impact factor: 3.534

View more
  20 in total

1.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

2.  Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations.

Authors:  Charina M Ramirez; Benny Liu; Amal Aqul; Anna M Taylor; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2011-02-02       Impact factor: 5.922

3.  The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.

Authors:  H W Frijlink; E J Franssen; A C Eissens; R Oosting; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

4.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

5.  Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.

Authors:  H Agashe; P Lagisetty; K Sahoo; D Bourne; B Grady; V Awasthi
Journal:  J Nanopart Res       Date:  2011-06-01       Impact factor: 2.253

6.  Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex.

Authors:  Naoshad Mohammad; Shivendra Vikram Singh; Parmanand Malvi; Balkrishna Chaube; Dipti Athavale; Muralidharan Vanuopadath; Sudarslal Sadasivan Nair; Bipin Nair; Manoj Kumar Bhat
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

7.  Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease.

Authors:  Atsushi Tamura; Nobuhiko Yui
Journal:  Sci Rep       Date:  2014-03-12       Impact factor: 4.379

8.  Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.

Authors:  Tyree H Kiser; Douglas N Fish; Christina L Aquilante; Joseph E Rower; Michael F Wempe; Robert MacLaren; Isaac Teitelbaum
Journal:  Crit Care       Date:  2015-02-03       Impact factor: 9.097

9.  Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice.

Authors:  P Y Grosse; F Bressolle; F Pinguet
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

10.  Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin.

Authors:  Moumita Hazra; Dalia Dasgupta Mandal; Tamal Mandal; Saikat Bhuniya; Mallika Ghosh
Journal:  Saudi Pharm J       Date:  2015-01-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.